News

Published on 10 Jan 2022 on Benzinga

45 Stocks Moving In Monday's Mid-Day Session


Article preview image

Check out these big penny stock gainers and losers

NYSE.QTWO price evolution
NASDAQ.BCRX price evolution
NYSE.STEM price evolution
NASDAQ.CDNA price evolution
NYSE.MYE price evolution
NASDAQ.PXLW price evolution
NYSE.BILL price evolution
NASDAQ.FOLD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Amicus Therapeutics Inc (FOLD) Q4 2024 Earnings Call Highlights: Strong Revenue...

Total Revenue: $528 million for the full year 2024, a 32% increase year over year. Galafold Reven...

GuruFocus.com · via Yahoo Finance 20 Feb 2025

Amicus Therapeutics, Inc. (FOLD): The Biotech Stock with Biggest Upside...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 17 Jan 2025

Amicus Therapeutics CEO Campbell sells $98,800 in stock By Investing.com

On November 6, Campbell sold 7,901 shares of common stock at an average price of $12.5048, totali...

Investing.com 8 Nov 2024

Amicus Therapeutics Inc (FOLD) Q3 2024 Earnings Call Highlights: Strong Revenue...

Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

Earnings call: Amicus Therapeutics reports robust Q3 growth, raises guidance By...

Amicus Therapeutics (NASDAQ: NASDAQ:FOLD) has reported a significant increase in revenue for the...

Investing.com 6 Nov 2024

Amicus Therapeutics Inc (FOLD) Q2 2024 Earnings Call Highlights: Strong Revenue...

Total Revenue: $127 million, a 34% increase year-over-year, or 36% on a constant currency basis....

GuruFocus.com · via Yahoo Finance 11 Oct 2024

Is Amicus Therapeutics, Inc. (FOLD) the Best Guru Stock To Buy Now?

We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have ...

Insider Monkey · via Yahoo Finance 24 Sep 2024

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q1 2024 Earnings Call Transcript May 9, 2024 Amicus Thera...

Insider Monkey via Yahoo Finance 8 May 2024

When Will Amicus Therapeutics, Inc. (NASDAQ:FOLD) Become Profitable?

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is possibly approaching a major achievement in its busine...

Simply Wall St. via Yahoo Finance 19 Apr 2024

Director Margaret Mcglynn Sells 15,000 Shares of Amicus Therapeutics Inc (FOLD)

Director Margaret Mcglynn has sold 15,000 shares of Amicus Therapeutics Inc (NASDAQ:FOLD) on Marc...

GuruFocus.com via Yahoo Finance 7 Mar 2024